Has Vinod Patwa, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,386 in general payments to Vinod Patwa, MD across 24 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Vinod Patwa, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Vinod Patwa, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Vinod Patwa, MD

Psychiatry · Rancho Mirage, CANPI 1609811132

Payments from drug & device makers

$1,386in general payments, 2019–2025

Across 24 payments — averaging $57.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Neurocrine Biosciences, Inc.$504
Alkermes, Inc.$274
Otsuka America Pharmaceutical, Inc.$250
Axsome Therapeutics, Inc.$232
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$126

What the payments were for

Food & beverage$1,386100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Neurocrine Biosciences, Inc.	11	$504
Alkermes, Inc.	8	$274
Otsuka America Pharmaceutical, Inc.	2	$250
Axsome Therapeutics, Inc.	2	$232
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$126

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,386 in reported general payments places this provider in the 75th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California →

Medicare billing

Part B allowed, 2024

$114,325

Medicare patients

164

Services billed

868

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Lurasidone Hcl	16	$6,290
Aripiprazole	148	$5,790
Perphenazine-AmitriptylinePerphenazine/Amitriptyline Hcl	66	$5,717
Bupropion XlBupropion Hcl	173	$5,573
Duloxetine Hcl	145	$4,018
Quetiapine Fumarate	108	$2,502
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine	20	$1,555
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	13	$1,511
Olanzapine	39	$1,432
Fluvoxamine Maleate	13	$1,335
Trazodone Hcl	109	$1,264
Lamotrigine	70	$1,212
Escitalopram Oxalate	58	$1,143
Vilazodone Hcl	14	$1,104
Modafinil	19	$1,003

Paid to pharmacies, not to this prescriber.

Other psychiatry in Rancho Mirage

Elly LeeIrvine$49.8M
Daniel ChuehOrange$17.9M
Eric ChavezSan Diego$15.5M
Lara ShirikjianTorrance$12.6M
John DuffySanta Ana$12M
Marina BusselPlaya Vista$12M
Sherry SoefjeOceanside$11.9M
Steven MacinaHuntington Beach$11.1M
Wakelin McNeelRosemead$11M
Donald AndersonBanning$10.5M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →